Common use of Authorized and Outstanding Capital Stock Clause in Contracts

Authorized and Outstanding Capital Stock. As of January 24, 2018, the authorized capital stock of the Company consists of (A) 90,000,000 shares of Common Stock, of which, 25,847,969 are issued and outstanding and 1,500,000 shares are reserved for issuance pursuant to Convertible Securities (as defined below) (other than the Warrants) exercisable or exchangeable for, or convertible into, shares of Common Stock and (B) 10,000,000 shares of Preferred Stock, none of which are issued and outstanding. As of March 7, 2018, 64,152,031 shares of Common Stock are held in the treasury of the Company.

Appears in 3 contracts

Samples: Securities Purchase Agreement (YayYo, Inc.), Securities Purchase Agreement (YayYo, Inc.), Securities Purchase Agreement (YayYo, Inc.)

AutoNDA by SimpleDocs

Authorized and Outstanding Capital Stock. As of January 24, 2018the date hereof, the authorized capital stock of the Company consists of (A) 90,000,000 900,000,000 shares of Common Stock, of which, 25,847,969 135,237,584 are issued and outstanding and 1,500,000 no shares are reserved for issuance pursuant to Convertible Securities (as defined below) (other than the Notes and the Warrants) exercisable or exchangeable for, or convertible into, shares of Common Stock and (B) 10,000,000 100,000 shares of Preferred Stock, none of which are issued and outstanding. As of March 7, 2018, 64,152,031 764,762,416 shares of Common Stock are held in the treasury of the Company.

Appears in 3 contracts

Samples: Securities Purchase Agreement (Cannabics Pharmaceuticals Inc.), Securities Purchase Agreement (Cannabics Pharmaceuticals Inc.), Securities Purchase Agreement (Cannabics Pharmaceuticals Inc.)

Authorized and Outstanding Capital Stock. As of January 24, 2018the date hereof, the authorized capital stock of the Company consists of (A) 90,000,000 100,000,000 shares of Common Stock, of which, 25,847,969 3,934,728 are issued and outstanding and 1,500,000 1,020,604 shares are reserved for issuance pursuant to Convertible Securities (as defined below) (other than the Notes and the Warrants) exercisable or exchangeable for, or convertible into, shares of Common Stock and (B) 10,000,000 12,500,000 shares of Preferred Stock, none of which are issued and outstanding. As of March 7, 2018, 64,152,031 95,044,668 shares of Common Stock are held in the treasury of the Company.

Appears in 2 contracts

Samples: Securities Purchase Agreement (Axion Power International, Inc.), Securities Purchase Agreement (Axion Power International, Inc.)

Authorized and Outstanding Capital Stock. As of January 24, 2018the date hereof, the authorized capital stock of the Company consists of (A) 90,000,000 500,000,000 shares of Common Stock, of which, 25,847,969 138,820,058 are issued and outstanding and 1,500,000 7,440,959 shares are reserved for issuance pursuant to Convertible Securities (as defined belowin the Convertible Notes) (other than the Convertible Notes and Warrants) exercisable or exchangeable for, or convertible into, shares of Common Stock and (B) 10,000,000 50,000,000 shares of Preferred Stock, none 142.8295125 of which are issued and outstanding. As of March 7, 2018, 64,152,031 No shares of Common Stock are held in the treasury of the Company.

Appears in 2 contracts

Samples: Securities Purchase Agreement (PARETEUM Corp), Omnibus Amendment (PARETEUM Corp)

Authorized and Outstanding Capital Stock. As of January 24, 2018the date hereof, the authorized capital stock of the Company Purchaser consists of (A) 90,000,000 746,666,667 shares of Common Stock, of which, 25,847,969 480,737,533 are issued and outstanding and 1,500,000 56,005,479 shares are reserved for issuance pursuant to Convertible Securities (as defined below) (other than the WarrantsShares) exercisable or exchangeable for, or convertible into, shares of Common Stock and (B) 10,000,000 shares of Preferred Stock, none of which are issued and outstanding. As of March 7, 2018, 64,152,031 No shares of Common Stock are held in the treasury of the CompanyPurchaser.

Appears in 2 contracts

Samples: Assignment and Assumption Agreement (HEXO Corp.), Assignment and Assumption Agreement (Tilray Brands, Inc.)

Authorized and Outstanding Capital Stock. As of January 24, 2018the date hereof, the authorized capital stock of the Company consists of (A) 90,000,000 200,000,000 shares of Common Stock, of which, 25,847,969 106,404,378 are issued and outstanding and 1,500,000 75,929,223 shares are reserved for issuance pursuant to Convertible Securities (as defined below) (other than the Notes and the Warrants) exercisable or exchangeable for, or convertible into, shares of Common Stock and (B) 10,000,000 5,000,000 shares of Preferred Stock, none of which are issued and outstanding. As of March 7, 2018, 64,152,031 No shares of Common Stock are held in the treasury of the Company.

Appears in 1 contract

Samples: Form of Securities Purchase Agreement (EnteroMedics Inc)

Authorized and Outstanding Capital Stock. As of January 24, 2018the date hereof, the authorized capital stock of the Company consists of (A) 90,000,000 314,800,000 shares of Common Stock, of which, 25,847,969 10,873,863 shares are issued and outstanding and 1,500,000 4,768,974 shares are reserved for issuance pursuant to Convertible Securities (as defined below) (other than the WarrantsCommon Shares) exercisable or exchangeable for, or convertible into, shares of Common Stock and (B) 10,000,000 100,000 shares of Preferred Stock, none of which are issued and outstanding. As of March 7, 2018, 64,152,031 No shares of Common Stock are held in the treasury of the Company.

Appears in 1 contract

Samples: Securities Purchase Agreement (Rock Creek Pharmaceuticals, Inc.)

Authorized and Outstanding Capital Stock. As of January 24, 2018the date hereof, the authorized capital stock of the Company consists of (A) 90,000,000 three hundred fifty million (350,000,000) shares of Common Stock, of which, 25,847,969 25,983,538 are issued and outstanding as of the date hereof and 1,500,000 shares 9,547,419 of which are reserved for issuance pursuant to Convertible Securities (as defined below) (other than the Warrants) ), in each case exercisable or exchangeable for, or convertible into, shares of Common Stock Stock, and (B) 10,000,000 ten million (10,000,000) shares of Preferred Stock, none of which are issued and outstanding. As of March 7, 2018, 64,152,031 No shares of Common Stock are held in the treasury of the Company.

Appears in 1 contract

Samples: Amendment and Exchange Agreement (Innovate Biopharmaceuticals, Inc.)

Authorized and Outstanding Capital Stock. As of January 24, 2018the date hereof, the authorized capital stock of the Company consists of (A) 90,000,000 150,000,000 shares of Common Stock, of whichwhich 60,563,456 (as of June 20, 25,847,969 2019) are issued and outstanding and 1,500,000 approximately 24,327,828 shares are reserved for issuance pursuant to Convertible Securities (as defined below) (other than the Warrants) exercisable or exchangeable for, or convertible into, shares of Common Stock and (B) 10,000,000 5,000,000 shares of Preferred Stock, none of which are issued and outstanding. As of March 7, 2018, 64,152,031 6,764,796 shares of Common Stock are held in the treasury of the Company.

Appears in 1 contract

Samples: Securities Purchase Agreement (Comscore, Inc.)

Authorized and Outstanding Capital Stock. As of January 24, 2018the date hereof, the authorized capital stock of the Company consists of (A) 90,000,000 500,000,000 shares of Common Stock, of which, 25,847,969 9,361,274 are issued and outstanding and 1,500,000 no shares are reserved for issuance pursuant to Convertible Securities (as defined below) (other than the Preferred Shares and the Warrants) exercisable or exchangeable for, or convertible into, shares of Common Stock and (B) 10,000,000 25,000,000 shares of Preferred Stock, none of which are issued and outstanding. As of March 7, 2018, 64,152,031 No shares of Common Stock are held in the treasury of the Company.

Appears in 1 contract

Samples: Securities Purchase Agreement (Diana Containerships Inc.)

Authorized and Outstanding Capital Stock. As of January 24, 2018the date hereof, the authorized capital stock of the Company consists of (A) 90,000,000 500,000,000 shares of Common Stock, of which, 25,847,969 47,269,804 are issued and outstanding and 1,500,000 79,764,691 shares are reserved for issuance pursuant to Convertible Securities (as defined below) (other than the Notes and the Warrants) exercisable or exchangeable for, or convertible into, shares of Common Stock and (B) 10,000,000 shares of Preferred Stock, none 148,758.53 of which are issued and outstanding. As of March 7, 2018, 64,152,031 No shares of Common Stock are held in the treasury of the Company.

Appears in 1 contract

Samples: Securities Purchase Agreement (TimefireVR Inc.)

Authorized and Outstanding Capital Stock. As of January 24August 27, 2018, the authorized capital stock of the Company consists of (A) 90,000,000 300,000,000 shares of Common Stock, of which, 25,847,969 13,495,394 are issued and outstanding and 1,500,000 approximately 960,201 shares are reserved for issuance pursuant to Convertible Securities (as defined below) (other than the Notes and the Warrants) exercisable or exchangeable for, or convertible into, shares of Common Stock and (B) 10,000,000 100,000,000 shares of Preferred Stock, none of which are issued and outstanding. As of March 7, 2018, 64,152,031 The Company is holding 158,689 shares of Common Stock are held in the treasury of the Company.

Appears in 1 contract

Samples: Securities Purchase Agreement (Cosmos Holdings Inc.)

Authorized and Outstanding Capital Stock. As of January 24, 2018the date hereof, the authorized capital stock of the Company consists of (A) 90,000,000 150,000,000 shares of Common Stock, of which, 25,847,969 2,070,861 are issued and 2,063,308 outstanding and 1,500,000 532,765 shares are reserved for issuance pursuant to Convertible Securities (as defined below) (other than the Preferred Shares and the Common Warrants) exercisable or exchangeable for, or convertible into, shares of Common Stock and (B) 10,000,000 5,000,000 shares of Preferred Stock, Stock none of which are issued and currently outstanding. As of March 7, 2018, 64,152,031 7,553 shares of Common Stock are held in the treasury of the Company.

Appears in 1 contract

Samples: Securities Purchase Agreement (Oblong, Inc.)

Authorized and Outstanding Capital Stock. As of January 24, 2018the date hereof, the authorized capital stock of the Company consists of (A) 90,000,000 500,000,000 shares of Common Stock, of which, 25,847,969 65,008,605 are issued and outstanding and 1,500,000 1,703,177 shares are reserved for issuance pursuant to Convertible Securities (as defined below) (other than the WarrantsWarrant Shares) exercisable or exchangeable for, or convertible into, shares of Common Stock and (B) 10,000,000 shares of Preferred Stock, none of which are issued and outstanding. As of March 7, 2018, 64,152,031 No shares of Common Stock are held in the treasury of the Company.

Appears in 1 contract

Samples: Securities Purchase Agreement (Duos Technologies Group, Inc.)

Authorized and Outstanding Capital Stock. As of January 24, 2018the date hereof, the authorized capital stock of the Company consists of (A) 90,000,000 750,000,000 shares of Common Stock, of which, 25,847,969 35,723,762 are issued and outstanding as of the date hereof and 1,500,000 shares 24,626,130 of which are reserved for issuance pursuant to Convertible Securities (as defined below) (other than the Warrants) Securities, in each case exercisable or exchangeable for, or convertible into, shares of Common Stock Stock, and (B) 10,000,000 50,000,000 shares of Preferred Stock, none of which are issued and outstanding. As of March 7, 2018, 64,152,031 No shares of Common Stock are held in the treasury of the Company.

Appears in 1 contract

Samples: Exchange Agreement (ShiftPixy, Inc.)

Authorized and Outstanding Capital Stock. As of January 24, 2018the date hereof, the authorized capital stock of the Company consists of (A) 90,000,000 20,000,000 shares of Common Stock, of which, 25,847,969 are one (1) share is issued and outstanding and 1,500,000 no shares are reserved for issuance pursuant to Convertible Securities (as defined below) (other than the Preferred Shares and the Warrants) exercisable or exchangeable for, or convertible into, shares of Common Stock and (B) 10,000,000 5,000,000 shares of Preferred Stock, none of which are issued and outstanding. As of March 7, 2018, 64,152,031 No shares of Common Stock are held in the treasury of the Company.

Appears in 1 contract

Samples: Securities Purchase Agreement (Allarity Therapeutics, Inc.)

Authorized and Outstanding Capital Stock. As Immediately prior to the consummation of January 24, 2018the transactions contemplated hereby, the authorized capital stock of the Company consists of (A) 90,000,000 200,000,000 shares of Common Stock, of which, 25,847,969 111,382,862 are issued and outstanding and 1,500,000 27,729,856 shares are reserved for issuance pursuant to Convertible Securities (as defined below) (other than the Warrants) below exercisable or exchangeable for, or convertible into, shares of Common Stock and (B) 10,000,000 shares of Preferred Stock, none of which are issued and outstanding. As of March 7, 2018, 64,152,031 No shares of Common Stock are held in the treasury of the Company.

Appears in 1 contract

Samples: Securities Purchase Agreement (Ampio Pharmaceuticals, Inc.)

Authorized and Outstanding Capital Stock. As of January 24, 2018the date hereof, the authorized capital stock of the Company consists of (A) 90,000,000 500,000,000 shares of Common Stock, of which, 25,847,969 44,840,276 are issued and outstanding and 1,500,000 52,901,098 shares are reserved for issuance pursuant to Convertible Securities (as defined below) (other than the Notes and the Warrants) exercisable or exchangeable for, or convertible into, shares of Common Stock and (B) 10,000,000 shares of Preferred Stock, none 154,319.54 of which are issued and outstanding. As of March 7, 2018, 64,152,031 No shares of Common Stock are held in the treasury of the Company.

Appears in 1 contract

Samples: Securities Purchase Agreement (TimefireVR Inc.)

Authorized and Outstanding Capital Stock. As of January 24, 2018the date hereof, the authorized capital stock of the Company consists of (A) 90,000,000 100,000,000 shares of Common Stock, of which, 25,847,969 21,608,144 are issued and outstanding and 1,500,000 4,373,898 shares are reserved for issuance pursuant to Convertible Securities (as defined below) (other than the WarrantsCommon Shares) exercisable or exchangeable for, or convertible into, shares of Common Stock and (B) 10,000,000 shares of Preferred Stock, none of which are issued and outstanding. As of March 7, 2018, 64,152,031 No shares of Common Stock are held in the treasury of the Company.

Appears in 1 contract

Samples: Securities Purchase Agreement (Super League Gaming, Inc.)

Authorized and Outstanding Capital Stock. As of January 24, 2018the date hereof, the authorized capital stock of the Company consists of (A) 90,000,000 500,000,000 shares of Common Stock, of which, 25,847,969 99,273,089 are issued and outstanding as of the date hereof and 1,500,000 shares 473,000 of which are reserved for issuance pursuant to Convertible Securities (as defined below) (other than the Warrants) Securities, in each case exercisable or exchangeable for, or convertible into, shares of Common Stock Stock, and (B) 10,000,000 Two Million shares of Preferred Stock, none of which are issued and outstanding. As of March 7, 2018, 64,152,031 No shares of Common Stock are held in the treasury of the Company.

Appears in 1 contract

Samples: Exchange Agreement (Delcath Systems, Inc.)

Authorized and Outstanding Capital Stock. As of January 24, 2018the date hereof, the authorized capital stock of the Company consists of (A) 90,000,000 1,000,000,000 shares of Common Stock, of which, 25,847,969 40,353,345 are issued and outstanding and 1,500,000 9,673,627 shares are reserved for issuance pursuant to Convertible Securities (as defined below) (other than the WarrantsNotes) exercisable or exchangeable for, or convertible into, shares of Common Stock and (B) 10,000,000 0 shares of Preferred Stock, none of which are issued and outstanding. As of March 7, 2018, 64,152,031 0 shares of Common Stock are held in the treasury of the Company.

Appears in 1 contract

Samples: Securities Purchase Agreement (Phunware, Inc.)

Authorized and Outstanding Capital Stock. As of January 24, 2018the date hereof, the authorized capital stock of the Company consists of (A) 90,000,000 750,000,000 shares of Common Stock, of which, 25,847,969 32,117,326 are issued and outstanding and 1,500,000 10,931,994 shares are reserved for issuance pursuant to Convertible Securities (as defined below) (other than the Notes and the Warrants) exercisable or exchangeable for, or convertible into, shares of Common Stock and (B) 10,000,000 50,000,000 shares of Preferred Stock, none of which are issued and outstanding. As of March 7, 2018, 64,152,031 No shares of Common Stock are held in the treasury of the Company.

Appears in 1 contract

Samples: Securities Purchase Agreement (ShiftPixy, Inc.)

Authorized and Outstanding Capital Stock. As of January 24, 2018the date hereof, the authorized capital stock of the Company consists of (A) 90,000,000 150,000,000 shares of Common Stock, of which, 25,847,969 49,336,052 are issued and outstanding and 1,500,000 24,617,754 shares are reserved for issuance pursuant to Convertible Securities (as defined below) (other than the WarrantsNotes) exercisable or exchangeable for, or convertible into, shares of Common Stock and (B) 10,000,000 1,800,000 shares of Series B Preferred Stock, none 1,179,872 of which are issued and outstanding. As of March 7, 2018, 64,152,031 0 shares of Common Stock are held in the treasury of the Company.

Appears in 1 contract

Samples: Securities Purchase Agreement (PAVmed Inc.)

AutoNDA by SimpleDocs

Authorized and Outstanding Capital Stock. As of January 24, 2018the date hereof, the authorized capital stock of the Company consists of (A) 90,000,000 100,000,000 shares of Common Stock, of which, 25,847,969 57,242,164 are issued and outstanding and 1,500,000 13,349,408 shares are reserved for issuance pursuant to Convertible Securities (as defined below) (other than the Common Shares and the Warrants) exercisable or exchangeable for, or convertible into, shares of Common Stock and (B) 10,000,000 shares of Preferred Stock, none of which are issued and outstanding. As of March 7, 2018, 64,152,031 No shares of Common Stock are held in the treasury of the Company.

Appears in 1 contract

Samples: Securities Purchase Agreement (Ampio Pharmaceuticals, Inc.)

Authorized and Outstanding Capital Stock. As of January 24, 2018the date hereof, the authorized capital stock of the Company consists of (A) 90,000,000 27,000,000 shares of Common Stock, of which, 25,847,969 14,074,701 are issued and 13,973,898 are outstanding and 1,500,000 6,923,407 shares are reserved for issuance pursuant to Convertible Securities (as defined below) (other than the Notes and the Warrants) exercisable or exchangeable for, or convertible into, shares of Common Stock and (B) 10,000,000 3,000,000 shares of Preferred Stock, none of which are issued and outstanding. As of March 7, 2018, 64,152,031 100,803 shares of Common Stock are held in the treasury of the Company.

Appears in 1 contract

Samples: Securities Purchase Agreement (Aditx Therapeutics, Inc.)

Authorized and Outstanding Capital Stock. As of January 24, 2018the date hereof, the authorized capital stock of the Company consists of (A) 90,000,000 500,000,000 shares of Common Stock, of which, 25,847,969 47,269,804 are issued and outstanding and 1,500,000 79,764,691 shares are reserved for issuance pursuant to Convertible Securities (as defined below) (other than the WarrantsNotes) exercisable or exchangeable for, or convertible into, shares of Common Stock and (B) 10,000,000 shares of Preferred Stock, none Stock of which 148, 758.54 are issued and outstanding. As of March 7, 2018, 64,152,031 No shares of Common Stock are held in the treasury of the Company.

Appears in 1 contract

Samples: Securities Purchase Agreement (TimefireVR Inc.)

Authorized and Outstanding Capital Stock. As of January 24, 2018the date hereof, the authorized capital stock of the Company consists of (A) 90,000,000 8,000,000 shares of Common Stock, of which, 25,847,969 2,069,339 are issued and outstanding and 1,500,000 5,855,738 shares are reserved for issuance pursuant to Convertible Securities (as defined below) (other than the Warrants) exercisable or exchangeable for, or convertible into, shares of Common Stock and (B) 10,000,000 shares of Preferred Stock, none 3,835 of which were previously issued and 908 of which are issued and currently outstanding. As of March 7, 2018, 64,152,031 No shares of Common Stock are held in the treasury of the Company.

Appears in 1 contract

Samples: Form of Securities Purchase Agreement (Sigma Labs, Inc.)

Authorized and Outstanding Capital Stock. As of January 24, 2018the date hereof, the authorized capital stock of the Company consists of (A) 90,000,000 150,000,000 shares of Common Stock, of which, 25,847,969 which 10,351,845 are issued and outstanding outstanding, and 1,500,000 9,319,316 shares are reserved for issuance pursuant to Convertible Securities (as defined below) (other than the Notes and the Warrants) exercisable or exchangeable for, or convertible into, shares of Common Stock and (B) 10,000,000 50,000,000 shares of Preferred Stock, none of which are issued and outstanding. As of March 7, 2018, 64,152,031 No shares of Common Stock are held in the treasury of the Company.

Appears in 1 contract

Samples: Securities Purchase Agreement (Real Goods Solar, Inc.)

Authorized and Outstanding Capital Stock. As of January 24, 2018the date hereof, the authorized capital stock of the Company consists of (A) 90,000,000 100,000,000 shares of Common Stock, of which, 25,847,969 63,527,995 are issued and outstanding and 1,500,000 outstanding, 1,920,944 shares are reserved for make-good shares’ issuance pursuant to Convertible Securities and 3,900,000 shares are reserved for the exercise of options (as defined below) (other than excluding the November Warrants and the Warrants) exercisable or exchangeable for, or convertible into, shares of Common Stock and (B) 10,000,000 shares of Preferred Stock, none of which are issued and outstanding. As of March 7, 2018, 64,152,031 487,155 shares of Common Stock are held in the treasury of the Company.

Appears in 1 contract

Samples: Securities Purchase Agreement (Kandi Technologies Group, Inc.)

Authorized and Outstanding Capital Stock. As of January 24, 2018the date hereof, the authorized capital stock of the Company consists of (A) 90,000,000 100,000,000 shares of Common Stock, of which, 25,847,969 52,016,432 are issued and outstanding and 1,500,000 7,689,408 shares are reserved for issuance pursuant to Convertible Securities (as defined below) (other than the Common Shares and the Warrants) exercisable or exchangeable for, or convertible into, shares of Common Stock and (B) 10,000,000 shares of Preferred Stock, none of which are issued and outstanding. As of March 7, 2018, 64,152,031 No shares of Common Stock are held in the treasury of the Company.

Appears in 1 contract

Samples: Form of Securities Purchase Agreement (Ampio Pharmaceuticals, Inc.)

Authorized and Outstanding Capital Stock. As of January 24, 2018the date hereof, the authorized capital stock of the Company consists of (A) 90,000,000 70,000,000 shares of Common Stock, of which, 25,847,969 10,694,844 are issued and outstanding and 1,500,000 3,192,719 shares are reserved for issuance pursuant to Convertible Securities (as defined below) (other than the Warrants) exercisable or exchangeable for, or convertible into, shares of Common Stock and (B) 10,000,000 2,000,000 shares of Preferred Stock, none of which are issued and outstanding. As of March 7, 2018, 64,152,031 No shares of Common Stock are held in the treasury of the Company.

Appears in 1 contract

Samples: Securities Purchase Agreement (Annovis Bio, Inc.)

Authorized and Outstanding Capital Stock. As of January 24, 2018the date hereof, the authorized capital stock of the Company consists of (A) 90,000,000 100,000,000 shares of Common Stock, of which, 25,847,969 44,600,411 are issued and outstanding and 1,500,000 24,566,900 shares are reserved for issuance pursuant to Convertible Securities (as defined below) (other than the WarrantsNotes) exercisable or exchangeable for, or convertible into, shares of Common Stock and (B) 10,000,000 1,800,000 shares of Series B Preferred Stock, none 1,156,391 of which are issued and outstanding. As of March 7, 2018, 64,152,031 0 shares of Common Stock are held in the treasury of the Company.

Appears in 1 contract

Samples: Securities Purchase Agreement (PAVmed Inc.)

Authorized and Outstanding Capital Stock. As of January 24, 2018the date hereof, the authorized capital stock of the Company consists of (A) 90,000,000 45,000,000 shares of Common Stock, of which, 25,847,969 10,761,773 are issued and outstanding and 1,500,000 zero shares are reserved for issuance pursuant to Convertible Securities (as defined below) (other than the Warrants) exercisable or exchangeable for, or convertible into, shares of Common Stock and (B) 10,000,000 39,810 shares of Preferred Stock, none of which are issued and outstanding. As of March 7, 2018, 64,152,031 Zero shares of Common Stock are held in the treasury of the Company.

Appears in 1 contract

Samples: Securities Purchase Agreement (SCWorx Corp.)

Authorized and Outstanding Capital Stock. As of January 24, 2018the date hereof, the authorized capital stock of the Company consists of (A) 90,000,000 250,000,000 shares of Common Stock, of which, 25,847,969 59,957,241 are issued and outstanding and 1,500,000 59,701,401 shares are reserved for issuance pursuant to Convertible Securities (as defined below) (other than the Notes and the Warrants) exercisable or exchangeable for, or convertible into, shares of Common Stock and (B) 10,000,000 30,000,000 shares of Preferred Stock, none zero (0) of which are issued and outstanding. As of March 7, 2018, 64,152,031 Zero (0) shares of Common Stock are held in the treasury of the Company.

Appears in 1 contract

Samples: Securities Purchase Agreement (Vinco Ventures, Inc.)

Authorized and Outstanding Capital Stock. As of January 24, 2018the date hereof, the authorized capital stock of the Company consists of (A) 90,000,000 50,000,000 shares of Common Stock, of which, 25,847,969 16,485,362 are issued and outstanding and 1,500,000 1,856,795 shares are reserved for issuance pursuant to Convertible Securities (as defined below) (other than the WarrantsNotes) exercisable or exchangeable for, or convertible into, shares of Common Stock and (B) 10,000,000 shares of Preferred Stock, none of which are issued and outstanding. As of March 7, 2018, 64,152,031 No shares of Common Stock are held in the treasury of the Company.

Appears in 1 contract

Samples: Securities Purchase Agreement (One Stop Systems, Inc.)

Authorized and Outstanding Capital Stock. As of January 24, 2018the date hereof, the authorized capital stock of the Company consists of (A) 90,000,000 170,000,000 shares of Common Stock, of which, 25,847,969 24,118,491 are issued and outstanding and 1,500,000 11,054,331 shares are reserved for issuance pursuant to Convertible Securities (as defined below) (other than the Notes and the Warrants) exercisable or exchangeable for, or convertible into, shares of Common Stock and (B) 10,000,000 shares of Preferred Stock, none of which are issued and outstanding. As of March 7, 2018, 64,152,031 1,757 shares of Common Stock are held in the treasury of the Company.

Appears in 1 contract

Samples: Securities Purchase Agreement (Delcath Systems, Inc.)

Authorized and Outstanding Capital Stock. As of January 24, 2018the date hereof, the authorized capital stock of the Company consists of (A) 90,000,000 500,000,000 shares of Common Stock, of which, 25,847,969 35,773,620 are issued and outstanding and 1,500,000 17,194,732 shares are reserved for issuance pursuant to Convertible Securities (as defined below) (other than the Common Shares and the Warrants) exercisable or exchangeable for, or convertible into, shares of Common Stock and (B) 10,000,000 50,000,000 shares of Preferred Stock, none of which are issued and outstanding. As of March 7, 2018, 64,152,031 No shares of Common Stock are held in the treasury of the Company.

Appears in 1 contract

Samples: Securities Purchase Agreement (PARETEUM Corp)

Authorized and Outstanding Capital Stock. As of January 24, 2018the date hereof, the authorized capital stock of the Company consists of (A) 90,000,000 500,000,000 shares of Common Stock, of which, 25,847,969 51,572,586 are issued and outstanding and 1,500,000 19,650,522 shares are reserved for issuance pursuant to Convertible Securities (as defined below) (other than the WarrantsCommon Shares) exercisable or exchangeable for, or convertible into, shares of Common Stock and (B) 10,000,000 50,000,000 shares of Preferred Stock, none of which are issued and outstanding. As of March 7, 2018, 64,152,031 No shares of Common Stock are held in the treasury of the Company.

Appears in 1 contract

Samples: Securities Purchase Agreement (PARETEUM Corp)

Time is Money Join Law Insider Premium to draft better contracts faster.